There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.
Abstract
Traditional Chinese Medicine (TCM) is the treasure of Chinese Nation and gained the
gradual acceptance of the international community. However, the methods and theories
of TCM understanding of diseases are lack of appropriate modern scientific characterization
systems. Moreover, traditional risk factors cannot promote to detection and prevent
those patients with coronary artery disease (CAD) who have not developed acute myocardial
infarction (MI) in time. To sum up, there is still no objective systematic evaluation
system for the therapeutic mechanism of TCM in the prevention and cure of cardiovascular
disease. Thus, new ideas and technologies are needed. The development of omics technology,
especially metabolomics, can be used to predict the level of metabolites in vivo
and diagnose the physiological state of the body in time to guide the corresponding
intervention. In particular, metabolomics is also a very powerful tool to promote
the modernization of TCM and the development of TCM in personalized medicine. This
article summarized the application of metabolomics in the early diagnosis, the discovery
of biomarkers and the treatment of TCM in CAD.
Author and article information
Journal
Title:
Chinese Journal of Natural Medicines
Abbreviated Title:
Chinese Journal of Natural Medicines